Detalhe da pesquisa
1.
Limitations of glycated albumin standardization when applied to the assessment of diabetes patients.
Clin Chem Lab Med
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874995
2.
A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome.
Int J Mol Sci
; 25(9)2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732117
3.
Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybutyrate Testing.
Clin Chem
; 69(5): 519-524, 2023 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919618
4.
The retinopathy-derived HbA1c threshold of 6.5% for type 2 diabetes also captures the risk of diabetic nephropathy in NHANES.
Diabetes Obes Metab
; 23(9): 2109-2115, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033191
5.
Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome.
Clin Endocrinol (Oxf)
; 90(1): 162-169, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339716
6.
Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study.
Clin Endocrinol (Oxf)
; 90(6): 805-813, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30866088
7.
Effects of acute insulin-induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes.
Diabetes Obes Metab
; 21(3): 533-540, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30264480
8.
Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus.
Diabetes Obes Metab
; 21(3): 569-574, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30311402
9.
New Laboratory Guidelines for Diabetes: Continuing the Collaboration between Clinical and Laboratory Medicine.
Clin Chem
; 69(8): 785-787, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473456
10.
Anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome.
Clin Endocrinol (Oxf)
; 88(2): 258-262, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29144548
11.
Cardiac Troponin as a Marker of Heart Failure Risk in Diabetes.
Clin Chem
; 68(10): 1232-1234, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35897125
12.
Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome.
Clin Endocrinol (Oxf)
; 86(3): 384-387, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27651218
13.
Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.
BMC Endocr Disord
; 17(1): 26, 2017 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28525998
14.
Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss.
BMC Endocr Disord
; 17(1): 41, 2017 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28705172
15.
The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study.
Ann Intern Med
; 162(9): 610-8, 2015 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25938991
16.
The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review.
Diabetologia
; 58(7): 1409-21, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25994072
17.
Current evidence and future perspectives on the effective practice of patient-centered laboratory medicine.
Clin Chem
; 61(4): 589-99, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646214
18.
Diet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop.
Br J Nutr
; 113(2): 239-48, 2015 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25498786
19.
The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls.
BMC Endocr Disord
; 15: 14, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880805
20.
Management of severe in-patient hyponatraemia: an audit in two teaching hospitals in Yorkshire, UK.
Scand J Clin Lab Invest
; 75(1): 1-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25342242